MedPath

Preoperative Biochemical Predictors of Outcome in Patients With Hip Fracture

Completed
Conditions
Hip Fracture
Registration Number
NCT01280253
Lead Sponsor
Region Skane
Brief Summary

The objective of the study is to identify biochemical predictors of morbidity and mortality in patients suffering from hip fracture. For this purpose blood samples are collected prehospitally or in the emergency department in patients with a suspected hip fracture. During the hospital stay medical history, anesthesiological management recorded. In addition, american society of anesthesiology physiological score (ASA), revised cardiac risk index (RCRI), and POSSUM score is calculated. Morbidity and mortality is recorded " in house", after 30 days, after 4 months and after 1 year. Biochemical predictors of outcome will be evaluated with logistic regression analysis. Biochemical predictors include pro-brain natriuretic peptide, lactate, pro-calcitonin, adrenomedullin, copeptin, cystatin c. The predictive value of the potential markers will be compared to that of ASA, RCRI and POSSUM.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
999
Inclusion Criteria
  • Patients presenting with out of hospital hip fracture at University Hospital Lund Sweden
  • Informed consent
  • Blood sampling within 3 hrs of first contact with healthcare
Exclusion Criteria
  • No consent can be obtained
  • Non-operative management
  • Followup through the Swedish National Quality for Hip fracture patients not possible
  • High energy trauma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality30 days
Secondary Outcome Measures
NameTimeMethod
Morbidity30 day

Infectious complications Cardiovascular complications Thromboembolic complications Respiratory complications Renal complications Surgical complications

Trial Locations

Locations (1)

Skane University Hospital, Lund

🇸🇪

Lund, Skane, Sweden

© Copyright 2025. All Rights Reserved by MedPath